Editas Medicine

-$0.20 (-1.37%) Today
-$0.10 (-0.70%) As of 8:06 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell EDIT and other ETFs, options, and stocks.

About EDIT

Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9).

CEO
Gilmore O’Neill
Employees
264
Headquarters
Cambridge, Massachusetts
Founded
2013

EDIT Key Statistics

Market cap
984.98M
Price-Earnings ratio
—
Dividend yield
—
Average volume
2.01M
High today
$15.07
Low today
$13.95
Open price
$14.42
Volume
1.92M
52 Week high
$73.03
52 Week low
$9.59

EDIT Earnings

-$1.00
-$0.67
-$0.33
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 3, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure